Trial · NCT00881894
Adverse events28
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 28
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Abnormal Sensation in Eye | Eye disorders | Treatment A (Test: PR2.1.1) | 1 | 51 | 1 |
| other | Abnormal Sensation in Eye | Eye disorders | Treatment B (Reference: PR1.0) | 1 | 51 | 1 |
| other | Nausea | Gastrointestinal disorders | Treatment A (Test: PR2.1.1) | 4 | 51 | 4 |
| other | Nausea | Gastrointestinal disorders | Treatment B (Reference: PR1.0) | 3 | 51 | 3 |
| other | Vomiting | Gastrointestinal disorders | Treatment A (Test: PR2.1.1) | 2 | 51 | 2 |
| other | Vomiting | Gastrointestinal disorders | Treatment B (Reference: PR1.0) | 1 | 51 | 1 |
| other | Application Site Pruritus | General disorders | Treatment A (Test: PR2.1.1) | 12 | 51 | 12 |
| other | Application Site Pruritus | General disorders | Treatment B (Reference: PR1.0) | 12 | 51 | 12 |
| other | Application Site Cold Feeling | General disorders | Treatment A (Test: PR2.1.1) | 1 | 51 | 1 |
| other | Application Site Cold Feeling | General disorders | Treatment B (Reference: PR1.0) | 0 | 51 | 0 |
| other | Fatigue | General disorders | Treatment A (Test: PR2.1.1) | 1 | 51 | 1 |
| other | Fatigue | General disorders | Treatment B (Reference: PR1.0) | 0 | 51 | 0 |
| other | Rhinitis | Infections and infestations | Treatment A (Test: PR2.1.1) | 0 | 51 | 0 |
| other | Rhinitis | Infections and infestations | Treatment B (Reference: PR1.0) | 1 | 51 | 1 |
| other | Headache | Nervous system disorders | Treatment A (Test: PR2.1.1) | 7 | 51 | 9 |
| other | Headache | Nervous system disorders | Treatment B (Reference: PR1.0) | 5 | 51 | 5 |
| other | Somnolence | Nervous system disorders | Treatment A (Test: PR2.1.1) | 2 | 51 | 2 |
| other | Somnolence | Nervous system disorders | Treatment B (Reference: PR1.0) | 3 | 51 | 3 |
| other | Syncope Vasovagal | Nervous system disorders | Treatment A (Test: PR2.1.1) | 2 | 51 | 2 |
| other | Syncope Vasovagal | Nervous system disorders | Treatment B (Reference: PR1.0) | 0 | 51 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00881894/events